Experimental cell therapy offers hope for rare blood disorder patients
Disease control
Not yet recruiting
This study is testing an experimental cell therapy called CK0801 for adults with aplastic anemia, a rare and serious bone marrow disorder. The treatment involves infusing specially prepared immune cells from donated umbilical cord blood to help restore the body's ability to make …
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC